Patent · US Expired

5H-benzodiazepin derivative

US5204343A · kind A · utility

6Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 1991
Grant dateApr 20, 1993
Priority date
Expiry dateOct 17, 2011

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine of formula (I) ##STR1## and pharmaceutically acceptable acid addition salts thereof, furthermore to a process for preparing these compounds. The compounds according to the invention possess valuable anxiolytic, antiaggressive and antidepressant effects and have at the same time favorable acute toxicity values, so they can be used to advantage in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.